Bruker Unveils timsOmni Functional Proteomics 2.0 Workflows for Deeper Proteoform and PTM Analysis

Reuters

02/23

Bruker Unveils timsOmni Functional Proteomics 2.0 Workflows for Deeper Proteoform and PTM Analysis

Bruker Corporation announced new Functional Proteomics 2.0 workflow advancements for its timsOmni mass spectrometer aimed at deeper characterization of disease-relevant proteoforms and post-translational modifications. The company said new releases of ProteoScape, OmniScape 2026b (including the OmniWave algorithm for scaled top-down proteoform identification), and GlycoScape add capabilities such as database-independent PTM discovery, eXd-enabled glycoproteomics, and AI-enhanced de novo peptide sequencing trained on more than seven million MS/MS spectra. The announcement reports these results now as newly enabled/introduced in current software releases, and does not say they were previously presented or will be presented at a future event.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202602230700BIZWIRE_USPR_____20260223_BW057286) on February 23, 2026, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2613878182"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2613878182\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2613878182?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-23 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2613878182","market":"nz","top_or_hot":-1,"title":"Bruker Unveils timsOmni Functional Proteomics 2.0 Workflows for Deeper Proteoform and PTM Analysis","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Bruker Unveils timsOmni Functional Proteomics 2.0 Workflows for Deeper Proteoform and PTM Analysis\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bruker Corporation announced new Functional Proteomics 2.0 workflow advancements for its timsOmni mass spectrometer aimed at deeper characterization of disease-relevant proteoforms and post-translational modifications. The company said new releases of ProteoScape, OmniScape 2026b (including the OmniWave algorithm for scaled top-down proteoform identification), and GlycoScape add capabilities such as database-independent PTM discovery, eXd-enabled glycoproteomics, and AI-enhanced de novo peptide sequencing trained on more than seven million MS/MS spectra. The announcement reports these results now as newly enabled/introduced in current software releases, and does not say they were previously presented or will be presented at a future event.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202602230700BIZWIRE_USPR_____20260223_BW057286) on February 23, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bruker Unveils timsOmni Functional Proteomics 2.0 Workflows for Deeper Proteoform and PTM Analysis</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBruker Unveils timsOmni Functional Proteomics 2.0 Workflows for Deeper Proteoform and PTM Analysis\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-23 20:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Bruker Unveils timsOmni Functional Proteomics 2.0 Workflows for Deeper Proteoform and PTM Analysis\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bruker Corporation announced new Functional Proteomics 2.0 workflow advancements for its timsOmni mass spectrometer aimed at deeper characterization of disease-relevant proteoforms and post-translational modifications. The company said new releases of ProteoScape, OmniScape 2026b (including the OmniWave algorithm for scaled top-down proteoform identification), and GlycoScape add capabilities such as database-independent PTM discovery, eXd-enabled glycoproteomics, and AI-enhanced de novo peptide sequencing trained on more than seven million MS/MS spectra. The announcement reports these results now as newly enabled/introduced in current software releases, and does not say they were previously presented or will be presented at a future event.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202602230700BIZWIRE_USPR_____20260223_BW057286) on February 23, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BRKR","symbol_name":"布鲁克","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL5k87g7:1","article_id":"2613878182","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2613878182","pubTimestamp":1771848090,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Bruker Corporation announced new Functional Proteomics 2.0 workflow advancements for its timsOmni mass spectrometer aimed at deeper characterization of disease-relevant proteoforms and post-translational modifications. The company said new releases of ProteoScape, OmniScape 2026b , and GlycoScape add capabilities such as database-independent PTM discovery, eXd-enabled glycoproteomics, and AI-enhanced de novo peptide sequencing trained on more than seven million MS/MS spectra. The announcement reports these results now as newly enabled/introduced in current software releases, and does not say they were previously presented or will be presented at a future event.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BRKR":"布鲁克","BK4121":"生命科学工具和服务","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC"},"translate_title":"布鲁克推出timsOmni功能蛋白质组学2.0工作流程，用于更深入的蛋白质形态和PTM分析","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BRKR":0.9},"content_text":"Bruker Unveils timsOmni Functional Proteomics 2.0 Workflows for Deeper Proteoform and PTM Analysis\n    \n\n        Bruker Corporation announced new Functional Proteomics 2.0 workflow advancements for its timsOmni mass spectrometer aimed at deeper characterization of disease-relevant proteoforms and post-translational modifications. The company said new releases of ProteoScape, OmniScape 2026b (including the OmniWave algorithm for scaled top-down proteoform identification), and GlycoScape add capabilities such as database-independent PTM discovery, eXd-enabled glycoproteomics, and AI-enhanced de novo peptide sequencing trained on more than seven million MS/MS spectra. The announcement reports these results now as newly enabled/introduced in current software releases, and does not say they were previously presented or will be presented at a future event.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202602230700BIZWIRE_USPR_____20260223_BW057286) on February 23, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}